Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-11 17:35:45 UTC |
---|
Update Date | 2022-03-07 02:52:29 UTC |
---|
HMDB ID | HMDB0030258 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | (+)-Erythraline |
---|
Description | (+)-Erythraline is found in green vegetables. (+)-Erythraline is an alkaloid from Erythrina glauca (gallito) Alitretinoin (9-cis-retinoic acid) is a naturally-occurring endogenous retinoid indicated for topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma. Alitretinoin inhibits the growth of Kaposi's sarcoma (KS) cells in vitro. Retinoic acid is the oxidized form of Vitamin A. It functions in determining position along embryonic anterior/posterior axis in chordates. It acts through Hox genes, which ultimately control anterior/posterior patterning in early developmental stages. Retinoic acid acts by binding to heterodimers of the retinoic acid receptor (RAR) and the retinoid X receptor (RXR), which then bind to retinoic acid response elements (RAREs) in the regulatory regions of direct targets (including Hox genes), thereby activating gene transcription. Retinoic acid receptors mediate transcription of different sets of genes of cell differentiation, thus it also depends on the target cells. (+)-Erythraline is one of the target genes is the gene of the retinoic acid receptor itself which occurs during positive regulation. Control of retinoic acid levels is maintained by a suite of proteins. Retinoic acid is the oxidized form of Vitamin A. It functions in determining position along embryonic anterior/posterior axis in chordates. It acts through Hox genes, which ultimately controls anterior/posterior patterning in early developmental stages (PMID: 17495912 ). It is an important regulator of gene expression during growth and development, and in neoplasms. Tretinoin, also known as retinoic acid and derived from maternal vitamin A, is essential for normal growth and embryonic development. (+)-Erythraline is an excess of tretinoin can be teratogenic. It is used in the treatment of psoriasis; acne vulgaris; and several other skin diseases. It has also been approved for use in promyelocytic leukemia (leukemia, promyelocytic, acute) |
---|
Structure | COC1CC23N(CC=C2C=C1)CCC1=C3C=C2OCOC2=C1 InChI=1S/C18H19NO3/c1-20-14-3-2-13-5-7-19-6-4-12-8-16-17(22-11-21-16)9-15(12)18(13,19)10-14/h2-3,5,8-9,14H,4,6-7,10-11H2,1H3 |
---|
Synonyms | Value | Source |
---|
Erythraline | HMDB |
|
---|
Chemical Formula | C18H19NO3 |
---|
Average Molecular Weight | 297.3484 |
---|
Monoisotopic Molecular Weight | 297.136493479 |
---|
IUPAC Name | 19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2(10),3,8,15,17-pentaene |
---|
Traditional Name | 19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2(10),3,8,15,17-pentaene |
---|
CAS Registry Number | 466-77-3 |
---|
SMILES | COC1CC23N(CC=C2C=C1)CCC1=C3C=C2OCOC2=C1 |
---|
InChI Identifier | InChI=1S/C18H19NO3/c1-20-14-3-2-13-5-7-19-6-4-12-8-16-17(22-11-21-16)9-15(12)18(13,19)10-14/h2-3,5,8-9,14H,4,6-7,10-11H2,1H3 |
---|
InChI Key | TVOFUERNMZTYRM-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as erythrinanes. These are erythrina alkaloids possessing either a 6-5-6-6-membered indoloisoquinoline core or a derivative thereof. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Erythrina alkaloids |
---|
Sub Class | Erythrinanes |
---|
Direct Parent | Erythrinanes |
---|
Alternative Parents | |
---|
Substituents | - Erythrinane skeleton
- Tetrahydroisoquinoline
- Benzodioxole
- Indole or derivatives
- Aralkylamine
- Benzenoid
- Pyrroline
- Tertiary amine
- Tertiary aliphatic amine
- Oxacycle
- Dialkyl ether
- Ether
- Azacycle
- Acetal
- Organoheterocyclic compound
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Organic nitrogen compound
- Amine
- Hydrocarbon derivative
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 120 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 6.30 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - (+)-Erythraline GC-MS (Non-derivatized) - 70eV, Positive | splash10-015i-0190000000-31a215c71d077d41cd3c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (+)-Erythraline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 10V, Positive-QTOF | splash10-0002-0090000000-4ed4932343e54c47b889 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 20V, Positive-QTOF | splash10-00kb-0090000000-3f45afeb82d24f91e26f | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 40V, Positive-QTOF | splash10-052o-1690000000-ea46bd1a5bb5184fcba8 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 10V, Negative-QTOF | splash10-0002-0090000000-e65fe867119975c81d74 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 20V, Negative-QTOF | splash10-0002-0090000000-118fb68f55dae0d84902 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 40V, Negative-QTOF | splash10-0f89-1190000000-17347a064f6a1d40eb77 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 10V, Positive-QTOF | splash10-0002-0090000000-620f87966eb750d6f48d | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 20V, Positive-QTOF | splash10-00kb-0090000000-e0c9e93842a5dcbc6faf | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 40V, Positive-QTOF | splash10-0159-0290000000-50da91a2cb3d44278298 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 10V, Negative-QTOF | splash10-0002-0090000000-f0a7b42101b1968126a5 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 20V, Negative-QTOF | splash10-0002-0090000000-6e7152719730c22b3e4a | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Erythraline 40V, Negative-QTOF | splash10-001v-0190000000-8022183ddbfa6a633fa5 | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|